Insulet (PODD) announced that Omnipod 5, compatible with both Dexcom G6 (DXCM) and Abbott (ABT) FreeStyle Libre 2 Plus continuous glucose monitor sensors, is now fully available in the U.K. and the Netherlands for individuals aged two years and older with type 1 diabetes. Omnipod 5 is the first and only tubeless automated insulin delivery system integrated with both of the leading CGM sensor brands, Dexcom and Abbott FreeStyle Libre.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD:
- Insulet view downgraded to Mixed from Positive at OTR Global
- Eaton, DraftKings among nine additions to Jefferies Franchise Picks list
- PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
- Insulet initiated with a Buy at Redburn Atlantic
- Blue Orca goes short Insulet, sees ‘immediate’ 15% share drop